Affordable Access

Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma.

Authors
  • Skiest, Daniel J
  • Crosby, Craig
Type
Published Article
Journal
AIDS
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Aug 15, 2003
Volume
17
Issue
12
Pages
1787–1793
Identifiers
PMID: 12891064
Source
Medline
License
Unknown

Abstract

Receipt of HAART after diagnosis is associated with a significantly longer survival in patients with AIDS-related CNS lymphoma.

Report this publication

Statistics

Seen <100 times